BUDAPEST, HUNGARY--(Marketwired - Jan 11, 2016) - Cromos™ Pharma, an international full-service CRO, has announced today that it has opened a representative office in Budapest, Hungary.
"With a population of 10 million people, the highest standard of medical care and great investigator and patient engagement, Hungary exemplifies an excellent setting for global clinical research," said Vlad Bogin, MD, FACP, CEO of Cromos™ Pharma. "This development comes on the heels of our recent expansion to Czech Republic and is in line with Cromos™ Pharma's overarching strategy to expand its geographic presence to the most promising clinical trial locations in Central and Eastern Europe."
About Cromos™ Pharma, LLC
Cromos™ Pharma, LLC is a contract research organization (CRO) with operations in the post-Soviet space and in Eastern/Central Europe. The company provides a full spectrum of trial-related services which include regulatory approvals, medical writing, feasibility assessments, monitoring, project management and warehousing. Cromos™ Pharma, LLC is a privately owned company.
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.